Michael R Rosen1, Richard B Robinson, Peter Brink
1Center for Molecular Therapeutics, Department of Pharmacology, Columbia University, 630 West 168 Street, PH 7 West-321, New York, NY 10032, USA. mrr1@columbia.edu
Researchers are developing biological pacemakers using gene or cell therapy to replace electronic devices. This study explored using the HCN2 gene in viral vectors or human mesenchymal stem cells (hMSCs) to create pacemaker function in dogs.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: